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PP2Aa b s t r a c t
Target of rapamycin complex 1 (TORC1) has a key role in cellular regulations in response to environ-
mental conditions. In yeast, Tip41 downregulates TORC1 signaling via activation of PP2A phospha-
tase. We show here that overexpression of TIPRL, a mammalian Tip41, suppressed
dephosphorylation of mechanistic TORC1 (mTORC1) substrates under amino acid withdrawal, and
knockdown of TIPRL conversely attenuated phosphorylation of those substrates after amino acid
refeeding. TIPRL associated with the catalytic subunit of PP2A (PP2Ac), which was required for
the TIPRL action on mTORC1 signaling. Collectively, unlike yeast TIP41, TIPRL has a positive effect
on mTORC1 signaling through the association with PP2Ac.
Structured summary of protein interactions:
PP2Ac physically interacts with TIPRL by anti bait coimmunoprecipitation (View Interaction: 1, 2)
PR65 physically interacts with PP2Ac by anti tag coimmunoprecipitation (View interaction)
TIPRL physically interacts with PP2Ac by anti tag coimmunoprecipitation (View Interaction: 1, 2)
alpha 4 physically interacts with PP2Ac by anti bait coimmunoprecipitation (View interaction)
PP2Ac physically interacts with PR65 and TIPRL by anti tag coimmunoprecipitation (View interaction)
PP2Ac physically interacts with TIPRL by anti tag coimmunoprecipitation (View interaction)
alpha 4 physically interacts with TIPRL by anti bait coimmunoprecipitation (View Interaction: 1, 2)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction phosphatidylinositol kinase-related kinase family and plays crucialTarget of rapamycin (TOR) is a serine/threonine protein kinase
highly conserved from yeast to mammal, which belongs to theroles in cellular processes such as cell growth and proliferation. In
mammal, mechanistic TOR (mTOR) exists as two distinct hetero-
oligomeric complexes, mTOR complex 1 (mTORC1) and mTORC2,
which are widely considered to be sensitive and insensitive to rap-
amycin, respectively [1]. mTORC1 signaling promotes anabolic
processes and inhibits catabolic processes by regulating phosphor-
ylation of its substrates including S6K, 4E-BP1, and ULK1, in re-
sponse especially to nutrients, such as amino acids, whereas
mTORC2 is primarily involved in cell survival adapting to
growth-factor signals through the phosphorylation of AGC kinases
including AKT and SGK1. Furthermore, signaling pathways medi-
ated by mTOR are implicated in a number of pathological condi-
tions [2].
It has been known that, in budding yeast, TOR phosphorylates
Tap42 (type 2A phosphatase-associated protein of 42 kDa), a protein
that associateswith thecatalyticC-subunitof PP2A(proteinphospha-
tase 2A) and PP2A-related phosphatases, Pph21, Pph22, and Sit4, as
well as other phosphorylation substrates including yeast AGCkinases
A. Nakashima et al. / FEBS Letters 587 (2013) 2924–2929 2925such as Ypk2 and Sch9 [3–6]. The phosphorylation of Tap42 by TOR
enhances its association with the C-subunit of the phosphatases,
and thereby dissociates the C-subunit from the complex with the
structural A- and regulatory B-subunits of PP2A [4]. In addition, it is
known that Tip41 (Tap42-interacting protein of 41 kDa), a conserved
interactingprotein of Tap42, plays an important role in the regulation
of PP2A function by Tap42 located downstreamof TOR [7]. Under the
conditions that TOR is inactivated by nitrogen starvation or rapamy-
cin treatment, Tip41 associates with Tap42 and inhibits its function,
and subsequently the activity of the phosphatases is stimulated lead-
ing to dephosphorylation of TOR downstream factors such as Npr1,
Gln3, and Msn2, and induction of autophagy [7–10]. Therefore,
Tip41 is indicated to have a negative effect on the rapamycin-sensi-
tive TOR signaling pathway in budding yeast.
The mammalian orthologs of Tap42 and Tip41 exist as a4 and
TIPRL (target of rapamycin signaling pathway regulator-like) (also
known as TIP and hTIP41), respectively. In contrast to the ﬁndings
in yeast, it has been shown that TIPRL directly associates with the
catalytic C-subunit of protein phosphatases, PP2A, PP4, and PP6,
although the mutual interaction of TIPRL with a4 is not established
[11–13]. The canonical PP2A exists as a heterotrimeric holoenzyme
consisting of the structural A- and regulatory B-subunits in addi-
tion to the C-subunit, PP2Ac [14]. PP2Ac bound to TIPRL does not
interact with the A- and B-subunits and show no phosphatase
activity in vitro [12,13]. Therefore, TIPRL is thought to suppress
the PP2A activity in vivo.
PP2A plays a key role in the regulation of a wide range of signal-
ing pathways such as mTOR, MAP (mitogen-activated protein) ki-
nase, and Wnt signalings [15], whereas TIPRL has been shown to
be concerned with two different signaling pathways mediated by
ATM (ataxia-telangiectasia mutated)/ATR (ATM- and Rad3-related)
kinases and by MKK7 (MAP kinase kinase 7) and JNK (c-Jun N-ter-
minal kinase) through the regulation of PP2A [12,16]. The involve-
ment of TIPRL in mTORC1 signaling, however, remains to be
elucidated.
In the present study, we investigated the role of TIPRL in
mTORC1 signaling using human cell lines and found that, unlike
the action of Tip41 on TORC1 signaling in budding yeast, TIPRL
facilitates amino-acid regulated mTORC1 signaling through its
association with PP2Ac.2. Materials and methods
2.1. cDNAs and siRNAs
Expression vectors of pMT2-FLAG-S6K1 and pCMV5-FLAG-4E-
BP1 were constructed as described [17]. To construct expression
vectors of TIPRL and the A-subunit (PR65) of PP2A, open reading
frames (ORFs) of human TIPRL and mouse PR65 were ampliﬁed
by PCR using human brain whole Marathon-Ready cDNA (Clon-
tech) and mouse spleen cDNA quick-clone (Clontech), respec-
tively, as templates, and were cloned into pcDNA3-HA,
pcDNA3.1()-myc-his6 (Invitrogen), or pME18S-3HA vector. The
coding region of rat PP2Acb was ampliﬁed by PCR using the
clone kindly gifted from Dr. Takayoshi Kuno (Kobe University)
as a template, and was cloned into pCMV5-FLAG. Point mutants
of TIPRL (D71L, Y79H, and M196V) and PP2Ac (Y307E) were gen-
erated using the QuikChange site-directed mutagenesis kit
(Stratagene), and the resulting expression vectors were desig-
nated HA-TIPRL (D71L), -TIPRL (Y79H), -TIPRL (M196V), and
FLAG-PP2Ac (Y307E).
Two small interfering RNAs (siRNA) were designed for targeting
the coding sequence of TIPRL: TIPRL-1, 50-CTGAGTGTGAAGATTA-
GAGTA-30 and TIPRL-2, 50-AAGCAGTTTGTGAGAAGCTAA-30. Control
siRNA was purchased from Qiagen.2.2. Cell culture and transfection
HEK293T and U2OS cells were maintained in Dulbecco’s modi-
ﬁed Eagles medium (DMEM) with 10% fetal bovine serum at 37 C
in a 5% CO2 incubator. Cells were transfected with expression vec-
tors using Lipofectamine reagent (Invitrogen) or FuGENE HD (Pro-
mega) according to the manufacturers’ protocol. For transfection
with siRNA, U2OS cells were transfected ﬁrst with each siRNA
using siPORT NeoFX transfection agent (Ambion), incubated for
24 h, and the second transfection was carried out using HiPerFect
transfection reagent (Qiagen) according to the manufacturers’ pro-
tocol. The cells were further cultured for two days before the
experiments. For starvation of serum and amino acids, the cells
were washed twice with DMEM lacking amino acids (DMEM-AA),
and cultured for 1 h in DMEM-AA. Then, the cells were incubated
for 15 min in DMEM or DMEM-AA in the absence of serum to
examine the effects of amino acids.
2.3. Antibodies and reagents
Rabbit polyclonal antibodies recognizing TIPRL anda4were pro-
duced against the following peptides by the antibody service of Im-
muno-Biological Laboratories: TIPRL (TIP256), ERIDPNPADSQKST
QV (amino acids 256–271); a4 (alpha323), DWKDTHPR
GYGNRQNMG (amino acids 323–339). Following antibodies were
purchased from the commercial sources: anti-FLAG (M2) and anti-
myc (9E10) antibodies from Sigma; anti-HA antibodies (12CA5
and 3F10) from Roche; anti-phospho-p70 S6 kinase (T389) (1A5),
anti-phospho-4E-BP (T37/46), and anti-4E-BP1 (53H11) antibodies
from Cell Signaling Technology; anti-PP2Ac (7A6) and anti-deme-
thylated PP2Ac (4b7) antibodies from Millipore; anti-PP2Aca for
immunoprecipitation from BD Transduction Laboratories; anti-
p70 S6 kinase (C-18), anti-PP2A-A subunit (4G7) antibodies, normal
rabbit and normal mouse immunoglobulins from Santa Cruz Bio-
technology. Horseradish peroxidase-conjugated anti-mouse and
anti-rabbit antibodies were purchased from Promega. Rapamycin
and PP242 were purchased fromMerck and Wako, respectively.
2.4. Immunoprecipitation
Cells were washed with ice-cold Dulbecco’s phosphate-buffered
saline (D-PBS), and lysed with ice-cold buffer A (20 mM Tris–HCl at
pH 7.5, 120 mM NaCl, 1 mM EDTA, 20 mM b-glycerophosphate,
5 mM EGTA, 0.3% CHAPS, 20 mM NaF, 1 mM phenylmethylsulfonyl
ﬂuoride, 2 lg/ml aprotinin, 4 lg/ml leupeptin, and 1 mM dithio-
threitol). After centrifugation, supernatants were incubated with
Protein G-Sepharose (GE Healthcare Bio-Sciences) and with the
indicated antibodies for 2 h, and the immunoprecipitate was
washed three times with buffer A.
2.5. Immunoblotting
Samples were separated by SDS–polyacrylamide gel electro-
phoresis, and proteins were transferred to a polyvinylidene diﬂuo-
ride membrane and probed with antibodies as indicated. Detection
of proteins was carried out using the ECL detection system (GE
Healthcare Bio-Sciences). When the FLAG-tagged and endogenous
4E-BP1 proteins were analyzed, heat-stable proteins were pre-
pared as described [18].
3. Results
3.1. TIPRL has a positive effect on amino-acid regulated mTORC1
signaling
Toelucidate the role of TIPRL inmTORC1signaling,weﬁrst exam-
ined the effect of TIPRL overexpression on the amino-acid regulated
2926 A. Nakashima et al. / FEBS Letters 587 (2013) 2924–2929mTORC1 signaling. HA-tagged TIPRL was co-expressed with either
FLAG-S6K1 or -4E-BP1 in HEK293T cells, and phosphorylation of
these mTORC1 substrates was assessed by immunoblotting after
immunoprecipitation fromthe cells incubated in thepresence or ab-
sence of amino acids. In the cells inwhich FLAG-S6K1was expressed
alone, the phosphorylation of Thr389, the mTORC1 recognition site,
was not detected in the starved cells, but induced by the amino acid
stimulation as previously described [19] (Fig. 1A). In contrast, when
HA-TIPRL was co-expressed, phosphorylation of FLAG-S6K1 was
sustained even under amino acid depletion, and the phosphoryla-
tion in the cells treated with amino acids was comparable to that
in cells without TIPRL co-expression (Fig. 1A). Similarly, HA-TIPRL
overexpression sustained phosphorylation of FLAG-4E-BP1, which
is represented by the mobility shifts, even under amino acid deple-
tion (Fig. 1B). In contrast, knockdownof TIPRLbyRNA interference in
U2OS cells, importantly, diminished phosphorylation of both S6K1
(Thr389) and 4E-BP1 (Thr37/46) induced by amino acid stimulation
compared to that in cells transfected with control siRNA (Fig. 1C).
Furthermore, sustained-S6K1 phosphorylation by TIPRL overex-
pression in amino acid depleted cells was abolished by the treat-
ment with two different types of mTOR speciﬁc inhibitors,
rapamycinandPP242 [20] (Fig. 1D). These results indicate that TIPRL
facilitates mTORC1 signaling regulated by amino acids.
3.2. TIPRL associates with PP2Ac
To gain insight into how TIPRL participates inmTORC1 signaling,
the screening for the associating proteinswith TIPRLwas carried out
using the yeast two-hybrid system, and PP2Ac was found (data not
shown). It has been shown that TIPRL associates with PP2Ac as well
as PP4 and PP6 [11–13]. Meanwhile, in ﬂy and mammalian cells,
PP2A, but not PP4 and PP6, is responsible for dephosphorylation of
S6K1 [21–23]. Therefore, we conﬁrmed and extended characteriza-
tionof the interactionbetweenTIPRL andPP2Ac inHEK293Tcells. To
this end, FLAG-PP2Ac was co-expressed with HA-TIPRL in HEK293T
cells and was immunoprecipitated with the anti-FLAG antibody. As
shown in Fig. 2A, HA-TIPRL was co-immunopuriﬁed with FLAG-Fig. 1. Positive effect of TIPRL on amino-acid regulated mTORC1 signaling. (A and B) HE
TIPRL, and the empty vectors as indicated were starved of serum and amino acids, an
transfected with siRNAs against TIPRL or with the control siRNA were starved of serum a
cells transfected with pMT2-FLAG-S6K1 and either pcDNA3-HA-TIPRL or the empty vecto
acids (AA) and mTOR inhibitors, 200 nM rapamycin (Rap) or 1 lM PP242 (PP) as indicate
(A and D), and, heat stable extracts were prepared from cells expressing FLAG-4E-BP
antibodies.PP2Ac. Furthermore, endogenous PP2Ac was immunoprecipitated
with endogenous TIPRL from non-transfected HEK293T cells, and
vice versa (Fig. 2B), showing that TIPRL binds to PP2Ac in vivo.
In budding yeast, Tip41 associates with Tap42 and is required for
dissociation of Tap42 from Sit4, a PP2A-related phosphatase [7]. In
mammalian cells, in contrast, the mutual interaction has not been
establishedamongTIPRL,a4, andPP2Ac [11–13]. Under the conditions
employed, the interaction between endogenous TIPRL and a4 was
found (Supplementary Fig. 1A), whereas a4 associated with PP2Ac
(Supplementary Fig. 1B), suggesting that a trimeric complex com-
posed of TIPRL, PP2Ac, and a4 is formed as previously reported [13].
In this study, we noted that the electrophoretic mobility of PP2Ac
associated with TIPRL is different from that associated with a4
(Fig. 2B and C, and Supplementary Fig. 1B). It is known that PP2Ac
undergoes post-translational modiﬁcations, such as methylation at
its carboxy-terminal leucine [14]. Therefore, we compared themeth-
ylation level of PP2Ac that was coimmunoprecipitated with TIPRL or
a4 using an antibody against demethylated PP2Ac. Fig. 2C shows that
the amount of demethylated PP2Ac coimmunoprecipitated with TIP-
RL wasmuch lower than that associated with a4. The substitution of
Tyr307 with glutamic acid in PP2Ac prevents its methylation [24].
We, thus, next examined the association between the PP2Ac-Y307E
mutant and TIPRL and found that the Y307E mutation attenuated
the associationwith TIPRL (Fig. 2D). These ﬁndings suggest that TIP-
RL predominantly binds to methylated PP2Ac.
3.3. PP2Ac forms a complex with TIPRL without A-subunit of PP2A
It is known that the canonical PP2A is a heterotrimeric holoen-
zyme complex composed of the A-, B-subunits and PP2Ac, and that
the A-subunit and PP2Ac form a core complex and the B-subunit
associates with it via the A-subunit scaffold [14]. Therefore, we
examined assembly of the A-subunit (PR65) and PP2Ac. Fig. 3A
shows that FLAG-PP2Ac was immunoprecipitated with both HA-
PR65 and TIPRL-mycHis, whereas the interaction between HA-
PR65 and TIPRL-mycHis was not observed, indicating that PP2Ac
forms a complex with TIPRL distinct from that with the A-subunit.K293T cells transfected with pMT2-FLAG-S6K1, pCMV5-FLAG-4E-BP1, pcDNA3-HA-
d then incubated with or without amino acids (AA) as indicated. (C) U2OS cells
nd amino acids, and then incubated with or without amino acids (AA). (D) HEK293T
r were starved of serum and amino acids, and then incubated with or without amino
d. Cell extracts were subjected to immunoprecipitation with the anti-FLAG antibody
1 (B). Protein extracts and immunoprecipitates were probed with the indicated
Fig. 2. Interaction of TIPRL with PP2Ac. HEK293T cells were transfected with pCMV5-FLAG-PP2Ac, pcDNA3-HA-TIPRL, and the empty vector as indicated (A), and with
pCMV5-FLAG-PP2Ac-WT (wild type), pCMV5-FLAG-PP2Ac-Y307E, or the empty vector (D). Cell extracts prepared from the transfected (A and D) and untransfected cells (B
and C) were subjected to immunoprecipitation, and protein extracts and immunoprecipitates were probed with the indicated antibodies. Normal rabbit immunoglobulin G
(NRG) and normal mouse immunoglobulin G (NMG) were used as controls. LC, light chain of immunoglobulin.
Fig. 3. Complex formation of PP2Ac with TIPRL and A-subunit of PP2A. HEK293T cells were transfected with pCMV5-FLAG-PP2Ac, pcDNA3.1()-TIPRL-myc-his6 (mycHis),
pME18S-3HA-PR65, and the empty vectors (A), and with pCMV5-FLAG-PP2Ac, pcDNA3-HA-TIPRL, and the empty vectors (B) as indicated. Where indicated as 2+, the twice as
much as amounts of the HA-TIPRL expression vector was employed. Cell extracts were subjected to immunoprecipitation, and protein extracts and immunoprecipitates were
probed with the indicated antibodies. Asterisk denotes non-speciﬁc bands. HC, heavy chain of immunoglobulin.
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FLAG-PP2Ac and endogenous PR65 (Fig. 3B), suggesting that TIPRL
restricts interaction of the A-subunit with PP2Ac.
3.4. The D71L mutation of TIPRL attenuates the association with PP2Ac
and the ability to keep S6K1 phosphorylation under amino acid
starvation
It has been shown that several single point mutations in TIPRL
decrease the binding afﬁnity to PP2Ac in the yeast-two hybrid
analysis [13]. We constructed three point mutants of TIPRL,
D71L, Y79H, and M196V, which are reported to have a decreased
association with PP2Ac, to examine their interaction with PP2Ac
in HEK293T cells. Fig. 4A shows that the point mutation of D71L se-
verely reduced the association with PP2Ac, whereas the association
of other TIPRL mutants, Y79H and M196V, with PP2Ac was compa-
rable to that of the wild type in disagreement with the results from
the yeast-two hybrid analysis [13]. We further examined whether
these TIPRL mutants sustain S6K1 phosphorylation under aminoacid depletion. Overexpression of the D71L mutant did not retain
S6K1 phosphorylation during amino acid starvation, although its
expression level was somewhat lower than those of others,
whereas the Y79H and M196V mutants showed sustained phos-
phorylation of the mTORC1 substrate as the wild type did
(Fig. 4B). These results suggest that the interaction of TIPRL with
PP2Ac is required for the persistence of S6K1 phosphorylation un-
der amino acid depletion.
4. Discussion
We demonstrate here that TIPRL facilitates mTORC1 signaling
that is regulated by amino acid availability; TIPRL overexpression
sustained phosphorylation of the mTORC1 substrates, S6K1 and
4E-BP1, even under the conditions that mTORC1 was inactivated
by amino acid withdrawal, whereas TIPRL knockdown attenuated
phosphorylation of these substrates by amino acid stimulation
(Fig. 1). Overexpression of TIPRL apparently reduced the expression
level of co-transfected S6K1, but it is not clear whether TIPRL af-
fects the protein level of S6K1. In addition, TIPRL was shown to
Fig. 4. Effect of a TIPRL mutant defective in association with PP2Ac on S6K1
phosphorylation. (A) HEK293T cells were transfected with pCMV5-FLAG-PP2Ac and
either pcDNA3-HA-TIPRL-WT, -D71L, Y79H, -M196V, or the empty vectors. (B)
HEK293T cells transfected with pMT2-FLAG-S6K1 and either pcDNA3-HA-TIPRL-
WT, -D71L, Y79H, -M196V, or the empty vector were starved of serum and amino
acids and then incubated with or without amino acids (AA). Cell extracts were
subjected to immunoprecipitation, and protein extracts and immunoprecipitates
were probed with the indicated antibodies.
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and D). The association of TIPRL with PP2Ac resulted in detaching
the A-subunit, PR65, from the heterotrimeric PP2A complex
(Fig. 3B). It seems that the B-subunit of PP2A is also dissociated
from the complex, because the B-subunit associates with the core
complex of the A-subunit and PP2Ac via the A-subunit [14]. Indeed,
the A- and B-subunits are absent from the complex of PP2Ac with
TIPRL [12]. As the B-subunit determines the substrate speciﬁcity of
PP2A [14], the TIPRL-PP2Ac complex without the A- and B-subunits
actually exhibits little phosphatase activity in vitro [12,13]. The
D71L mutation in TIPRL eliminated the association with PP2Ac
and the ability to sustain mTORC1 signaling (Fig. 4). The D71 resi-
due, which is conserved among the TIPRL orthologs in human, frog,
ﬁsh, ﬂy, plant, and yeast [13], would be important for the interac-
tion with PP2Ac. Taken together, it is most plausible that TIPRL
contributes positively to mTORC1 signaling via inhibiting the
PP2A activity.
As compared to the function of TIPRL observed in mammalian
cells, yeast Tip41 upregulates the activity of PP2A or PP2A-related
phosphatases by directly inhibiting Tap42 action on the phospha-
tases [7,8]. Tip41, thus, leads to dephosphorylation of the TOR
effectors by activating the phosphatases [7–10]. In contrast, Ging-
ras et al. [11] showed the direct interaction of Tip41 with PP2A or
PP2A-related phosphatases in the yeast two-hybrid analysis,
although the physiological action of the interaction remains un-
clear. In addition, Tip41 appears to be phosphorylated in a rapamy-
cin-sensitive manner, suggesting that Tip41 is a downstream of
TORC1 in yeast [7]. It remains to be determined whether TIPRL is
a substrate of mTORC1, but in our hands, recombinant TIPRL was
not phosphorylated in the in vitro kinase assay of mTOR (data
not shown). Therefore, it seems that Tip41/TIPRL obtained func-
tional divergence during the course of evolution between budding
yeast and mammal.
Recently, it has been reported that highly elevated TIPRL
expression is seen in several hepatocellular carcinoma (HCC) tis-
sues and HCC cell lines, and that the increased TIPRL gene product
prevents prolonged activation of MKK7-JNK signaling through
mediating the association between MKK7 and PP2A and promoting
MKK7 dephosphorylation [16]. This action of TIPRL appears to con-tribute to resistance of HCC cells to apoptosis induced by tumor
necrosis factor-related apoptosis-inducing ligand (TRAIL). In con-
trast, it is known that aberrant upregulation of the mTOR pathways
including mTORC1 signaling is observed in up to 50% of HCC tu-
mors, and that, in a number of studies using chemotherapeutic
drugs, inhibition of mTORC1 or synergistic inhibition of mTORC1
and other complementary pathways, such as the PI3K-AKT path-
way, prevents the proliferation of HCC cells and HCC tumors
[25]. So far, there is no direct evidence that increased TIPRL expres-
sion in HCC causes dysregulation of the mTORC1 signaling; how-
ever, the results that combination of TIPRL knockdown and TRAIL
treatment causes apoptosis of HCC cells [16] raise a possibility that
the elevated TIPRL expression is involved in mTORC1 dysregulation
and the expansion of HCC cells.
TIPRL has been shown to play as a negative regulator of PP2A in
the ATM/ATR signaling pathway [12] as in the case of mTORC1 sig-
naling. In contrast, in MKK7-JNK signaling, TIPRL facilitates the
interaction between MKK7 and PP2A, which is likely to enhance
the impact of PP2A on MKK7 and inhibit its kinase activity to phos-
phorylate JNK [16]. TIPRL, therefore, seems to control the PP2A
activity by distinct mechanisms. Further studies are needed to clar-
ify how TIPRL exhibits its effects on the PP2A activity to regulate
the different signaling pathways.
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